|
|
| Phases of Development | Preclinical | Phase I | Phase I/II | Phase II | Phase III | Phase IV | Registration | Approved | Marketed |
|---|
| Autoimmune | 10 | 3 | 2 | 8 | 3 | 1 | 1 | 1 | 5 | | Cancer | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Dermatology | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | | Gastrointestinal | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Infectious | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | | Inflammation | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | | Neurology | 1 | 1 | 1 | 2 | 0 | 0 | 0 | 0 | 1 | | Ophthalmic | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | | Pulmonary | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Transplant | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Tumor necrosis factor (TNF) alpha